Long-term dual antithrombotic therapy (DAT): is it efficient and safe in women?

Affiliations

¹ Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.

Editorial

Meinrad Gawaz. Cardiovasc Res. 2021.

. 2021 Feb 22;117(3):653-654.

doi: 10.1093/cvr/cvaa169.

¹ Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.

No abstract available

Comment on

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease.
Liang Y, Zhu J, Liu L, Anand SS, Connolly SJ, Bosch J, Guzik TJ, O'Donnell M, Dagenais GR, Fox KA, Shestakovska O, Berkowitz SD, Muehlhofer E, Keller L, Yusuf S, Eikelboom JW; COMPASS Investigators. Liang Y, et al. Cardiovasc Res. 2021 Feb 22;117(3):942-949. doi: 10.1093/cvr/cvaa100. Cardiovasc Res. 2021. PMID: 32289159 Clinical Trial.